Looks like price is respecting trendline / uptrend.
Price is within range. Needs to break above resistance and stay above for bullish confirmation.
Next target I would imagine a sell off unless FDA approval or some super bullish news is released and it gaps up (possible with these lower cap stocks).
Overall lots of bullish news, Novartis partnership + FDA Fast Track for Remestemcell-L
Price is within range. Needs to break above resistance and stay above for bullish confirmation.
Next target I would imagine a sell off unless FDA approval or some super bullish news is released and it gaps up (possible with these lower cap stocks).
Overall lots of bullish news, Novartis partnership + FDA Fast Track for Remestemcell-L
注释
Sadly bad news came out and the trend was invalidated - trading just above 78.6% area. I'm in quite a rough drawdown on my positions but you live and you learn. Biotcech stocks are highly risky!
*Not Financial Advice*
*Only Risk What You Can Afford To Lose*
*Just Ideas, Not Investment Advice*
t.me/AndyDTrades
x.com/AndyDTrades
*Trade At Your Own Risk*
*Only Risk What You Can Afford To Lose*
*Just Ideas, Not Investment Advice*
t.me/AndyDTrades
x.com/AndyDTrades
*Trade At Your Own Risk*
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
*Not Financial Advice*
*Only Risk What You Can Afford To Lose*
*Just Ideas, Not Investment Advice*
t.me/AndyDTrades
x.com/AndyDTrades
*Trade At Your Own Risk*
*Only Risk What You Can Afford To Lose*
*Just Ideas, Not Investment Advice*
t.me/AndyDTrades
x.com/AndyDTrades
*Trade At Your Own Risk*
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。